Form 4: Puma Biotechnology Director Michael Miller Sells Shares

Director Michael Miller sold 23,358 shares of Puma Biotechnology (PBYI) at an average price of $3.4877 on August 12, 2024.

Summary

• On August 12, 2024, Michael Patrick Miller, a director of Puma Biotechnology, sold 23,358 shares of common stock.
• The shares were sold at a weighted average price of $3.4877.
• The price range for the sales was between $3.4201 and $3.5501.
• Following the transaction, Miller directly owns 47,000 shares of Puma Biotechnology.
• The filing also corrects an error in a previous Form 4 filed on June 21, 2024, regarding the amount of shares held.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a transaction. The director selling shares could be interpreted negatively, but without further context, it's a routine disclosure.

Negatives

• A director selling shares could be perceived negatively by investors.

Risks

• Director share sales can sometimes signal a lack of confidence in the company's future prospects, potentially impacting investor sentiment.

Industry Context

Director share sales are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects.

Key Dates